INSUGEN Trademark

Trademark Overview

On Wednesday, September 27, 2017, a trademark application was filed for INSUGEN with the United States Patent and Trademark Office. The USPTO has given the INSUGEN trademark a serial number of 87624230. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 17, 2021. This trademark is owned by Biocon Limited. The INSUGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diabetes
insugen

General Information

Serial Number87624230
Word MarkINSUGEN
Filing DateWednesday, September 27, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 17, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 2, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiocon Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBangalore 560100
IN
Party NameBiocon Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBangalore 560100
IN

Trademark Events

Event DateEvent Description
Monday, May 17, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 17, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 14, 2020EXTENSION 5 GRANTED
Friday, July 24, 2020EXTENSION 5 FILED
Wednesday, August 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 24, 2020TEAS EXTENSION RECEIVED
Tuesday, March 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 20, 2020EXTENSION 4 GRANTED
Friday, March 20, 2020EXTENSION 4 FILED
Friday, March 20, 2020TEAS EXTENSION RECEIVED
Thursday, September 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2019EXTENSION 3 GRANTED
Tuesday, September 17, 2019EXTENSION 3 FILED
Tuesday, September 17, 2019TEAS EXTENSION RECEIVED
Friday, March 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2019EXTENSION 2 GRANTED
Wednesday, March 13, 2019EXTENSION 2 FILED
Wednesday, March 13, 2019TEAS EXTENSION RECEIVED
Friday, September 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 12, 2018EXTENSION 1 GRANTED
Wednesday, September 12, 2018EXTENSION 1 FILED
Wednesday, September 12, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 4, 2018ASSIGNED TO EXAMINER
Monday, October 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 30, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

insugen diabetes treating preparations pharmaceutical